In September 2022, Indonesia International Institute for Life Sciences (i3L) and Merck signed a Memorandum of Understanding (MoU) on technical collaboration. The MoU aims to boost Indonesian biopharmaceuticals by strengthening the workforce and the younger generation.
This collaboration would only be possible by utilizing Merck’s leadership and experience in bioprocessing. i3L will also provide scientific experiences and demonstrate the state-of-the-art facility.
